Forbes September 30, 2024
Dr. Sai Balasubramanian, M.D., J.D.

Nvidia has always sought to invest in valuable innovation. Its decades long dedication to building meaningful products and attempting to revolutionize the hardware industry has largely paid off; from its seminal work in gaming to its latest progress with chips that have been essential to the development of generative AI, the company has been successful without a doubt.

However, although most think of Nvidia as purely a hardware organization, the company is also rapidly investing resources in other arenas— and NVentures, which is the company’s venture capital arm, is leading the charge with numerous investments in healthcare.

The latest investment by the VC arm was announced earlier this month, which entailed a significant contribution, along with other investment partners, to...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: AI (Artificial Intelligence), Investments, Technology, Trends
The AI Leadership Crisis: Why Chief AI Officers Are Failing (And How To Fix It)
HIMSS25 Tackles AI, Cybersecurity and Workforce Readiness Amid Regulatory Uncertainty
Health Systems Want Deep Guidance from Their Vendors When it Comes to AI, KLAS Finds
"Humans in the loop" make AI work — for now
GenAI and the revolution of drug development

Share This Article